HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Deborah Morley Paul Spence Robert Dowling Bart Meyns Bartley Griffith Daniel Burkhoff Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Morley, D. Articles by Burkhoff, D. Search for Related Content PubMed PubMed Citation Articles by Morley, D. Articles by Burkhoff, D. Related Collections Congestive Heart Failure Mechanical Circulatory Assistance

J Thorac Cardiovasc Surg 2007;133:21-28
© 2007 The American Association for Thoracic Surgery

Cardiopulmonary Support and Physiology

Hemodynamic effects of partial ventricular support in chronic heart failure: Results of simulation validated with in vivo data

^a Department of Clinical Affairs, CircuLite, Inc, Hackensack, NJ
^b Department of Surgery, University of Louisville, Louisville, Kentucky
^c Center for New Media Teaching and Learning, Columbia University, New York, NY
^d Louisville, Ky
^e Department of Surgery, University of Leuven, Leuven, Belgium
^f Department of Surgery, University of Maryland, Baltimore, Maryland
^g Cardiovascular Research Foundation, Orangeburg, NY

Received for publication November 22, 2005; revisions received June 9, 2006; accepted for publication July 7, 2006.

^_* Address for reprints: Deborah Morley, PhD, CircuLite, Inc, Clinical and Regulatory, 401 Hackensack Ave, Hackensack, NJ 07601 (Email: dmorley{at}circulite.net).

OBJECTIVE: Current left ventricular assist devices are designed to provide full hemodynamic support for patients with end-stage failing hearts, but their use has been limited by operative risks, low reliability, and device-related morbidity. Such concerns have resulted in minimum use of left ventricular assist devices for destination therapy. We hypothesize that partial circulatory support, which could be achieved with small pumps implanted with less-invasive procedures, might expand the role of circulatory support devices for treatment of heart failure.

METHODS: We examine the hemodynamic effects of partial left ventricular support using a previously described computational model of the cardiovascular system. Results from simulations were validated by comparison with an in vivo hemodynamic study.

RESULTS: Simulations demonstrated that partial support (2-3 L/min) increased total cardiac output (left ventricular assist device output plus native heart output) by more than 1 L/min and decreased left ventricular end-diastolic pressure by 7 to 10 mm Hg with moderate-to-severe heart failure. Analyses showed that the hemodynamic benefits of increased cardiac output and decreased left ventricular end-diastolic pressure are greater in less-dilated and less-dysfunctional hearts. Both the relationships between ventricular assist device flow and cardiac output and ventricular assist device flow and left atrial pressure predicted by the model closely approximated the same relationships obtained during hemodynamic study in a bovine heart failure model.

CONCLUSIONS: Results suggest that a pump with a flow rate of 2 to 3 L/min could meaningfully affect cardiac output and blood pressure in patients with advanced compensated heart failure. The development of small devices capable of high reliability and minimal complications that can be implanted with less-invasive techniques is supported by these findings.